Prof. of the Department of Immunology and Molecular Medicine, of the University of Sri Jayewardenepura Neelika Malavige says according to the expert, whose work led to the development of the Oxford/AstraZeneca COVID-19 jab, the virus will eventually become like other coronaviruses that circulate widely and cause a common cold.
Prof. Malavige said the virus will weaken over time and through vaccinations, can be brought to manageable levels.
Prof. Malavige noted around 63 percent of the Sri Lankan population has received at least one dose of a vaccine against COVID-19 while 52 percent of the population is fully vaccinated.
Prof. Malavige added based on the detection of new variants of the coronavirus; they may have to vaccinate high-risk groups annually.
She said by taking both doses of a vaccine before contracting COVID-19 or obtaining the vaccine after being infected will boost antibodies in one’s immune system against the virus.
Prof. Neelika Malavige said therefore the risk of contracting COVID-19 for a second time is very minimal.